Brain tumor surgery: new drug may cut stroke risk
NCT ID NCT07520370
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the anti-inflammatory drug ulinastatin can prevent strokes in people having brain tumor removal. About 1,370 patients will receive either ulinastatin or a placebo before and after surgery. The goal is to see if the drug lowers the chance of having a stroke within a week after the operation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ulinastatin (an anti-inflammatory drug given intravenously)
- What this could lead to
- If it works, this could provide a simple way to reduce stroke risk after brain tumor surgery, improving recovery and safety.
- What could go wrong
- This is a single-center trial that hasn't started yet. The drug may not reduce strokes, and there is a small risk of allergic reactions or side effects from the drug.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal zaps could reboot breathing after brain injury
- Can brain scans reveal hidden language struggles after stroke?
- Can trained immune cells outsmart brain tumors?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- A tablet test aims to catch hidden attention and memory problems after stroke
- Can a gentle ear zap supercharge stroke rehab at home?